Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2025-07-31 00:00:00 ET · period of report 2025-07-30 · accession 0000950170-25-100882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-31 | 2025-07-30 | CRDF | PACE GARY W | Dir | P - Purchase | $2.45 | +275.0K | 1.33M | +26% | +$673.8K | |
| I | 2025-07-31 | 2025-07-30 | CRDF | PACE GARY W | Dir | P - Purchase | $2.45 | +15.0K | 1.35M | +1% | +$36.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-30 | P | A | 275,000 | $2.45 | 1,330,676 | D By minor child | — | — | |
| 2 | Common | Common Stock | 2025-07-30 | P | A | 15,000 | $2.45 | 1,345,676 | I | — | — |